Form 4 for MDT Medtronic
Accepted 2021-08-26 00:00:00 ET · period of report 2021-08-25 · accession 0001127602-21-024367 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-26 | 2021-08-25 | MDT | Salmon Sean | EVP, Pres Diabetes, Cardiovasc | S - Sale+OE | $134.08 | -28.4K | 33.3K | -46% | -$3.81M |
| DM | 2021-08-26 | 2021-08-25 | MDT | Salmon Sean | EVP, Pres Diabetes, Cardiovasc | M - OptEx | $38.71 | +28.4K | 40.6K | +233% | +$1.10M |
| DM | 2021-08-26 | 2021-08-25 | MDT | Salmon Sean | EVP, Pres Diabetes, Cardiovasc | M - OptEx | $0.00 | -28.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-08-25 | S | D | 7,290 | $134.09 | 33,329 | D | — | — | |
| 2 | Common | Ordinary Shares | 2021-08-25 | M | A | 2,577 | $38.81 | 35,906 | D | — | — | |
| 3 | Common | Ordinary Shares | 2021-08-25 | S | D | 21,129 | $134.08 | 33,329 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.05 to $134.16 inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Ordinary Shares | 2021-08-25 | M | A | 21,129 | $38.81 | 54,458 | D | — | — | |
| 5 | Common | Ordinary Shares | 2021-08-25 | M | A | 4,713 | $38.20 | 40,619 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-08-25 | M | D | 4,713 | $0.00 | 0 | D | $38.20 · 2013-04-30 to 2022-04-30 | 4,713 Ordinary Shares | (F2) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of the grant. |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-08-25 | M | D | 2,577 | $0.00 | 0 | D | $38.81 · 2013-07-30 to 2022-07-30 | 2,577 Ordinary Shares | (F2) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of the grant. |
| 8 | Derivative | Stock Option (Right to Buy) | 2021-08-25 | M | D | 21,129 | $0.00 | 0 | D | $38.81 · 2013-07-30 to 2022-07-30 | 21,129 Ordinary Shares | (F2) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of the grant. |